Virtu Financial’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-14,838
| Closed | -$1.02M | – | 1554 |
|
|
2024
Q2 | $1.02M | Sell |
14,838
-48,413
| -77% | -$3.23M | 0.07% | 292 |
|
|
2024
Q1 | $4.63M | Buy |
+63,251
| New | +$4.86M | 0.35% | 35 |
|
|
2023
Q1 | – | Sell |
-8,274
| Closed | -$710K | – | 1716 |
|
|
2022
Q4 | $710K | Buy |
8,274
+3,860
| +87% | +$306K | 0.09% | 197 |
|
|
2022
Q3 | $272K | Buy |
+4,414
| New | +$278K | 0.02% | 702 |
|
|
2022
Q2 | – | Sell |
-31,185
| Closed | -$1.85M | – | 1763 |
|
|
2022
Q1 | $1.85M | Buy |
+31,185
| New | +$1.99M | 0.14% | 109 |
|
|
2020
Q4 | – | Sell |
-10,741
| Closed | -$679K | – | 1556 |
|
|
2020
Q3 | $679K | Buy |
+10,741
| New | +$745K | 0.12% | 203 |
|
|
2019
Q4 | $2.29M | Sell |
35,292
-15,688
| -31% | -$1.02M | 0.22% | 86 |
|
|
2019
Q3 | $3.23M | Sell |
50,980
-15,895
| -24% | -$1.04M | 0.25% | 55 |
|
|
2019
Q2 | $4.52M | Buy |
66,875
+36,243
| +118% | +$2.38M | 0.26% | 44 |
|
|
2019
Q1 | $1.99M | Sell |
30,632
-4,492
| -13% | -$299K | 0.11% | 135 |
|
|
2018
Q4 | $2.2M | Buy |
+35,124
| New | +$2.45M | 0.12% | 124 |
|
|
2018
Q3 | – | Sell |
-2,925
| Closed | -$207K | – | 1781 |
|
|
2018
Q2 | $207K | Sell |
2,925
-4,890
| -63% | -$345K | 0.01% | 1483 |
|
|
2018
Q1 | $589K | Sell |
7,815
-27,388
| -78% | -$2.18M | 0.03% | 620 |
|
|
2017
Q4 | $2.52M | Buy |
35,203
+1,359
| +4% | +$103K | 0.13% | 138 |
|
|
2017
Q3 | $2.74M | Buy |
+33,844
| New | +$2.59M | 0.14% | 105 |
|
|
2017
Q1 | – | Sell |
-5,121
| Closed | -$367K | – | 469 |
|
|
2016
Q4 | $367K | Sell |
5,121
-817
| -14% | -$60.7K | 0.04% | 315 |
|
|
2016
Q3 | $470K | Buy |
+5,938
| New | +$482K | 0.08% | 213 |
|
|
2016
Q1 | – | Sell |
-11,558
| Closed | -$1.17M | – | 438 |
|
|
2015
Q4 | $1.17M | Buy |
+11,558
| New | +$1.2M | 0.17% | 128 |
|
|
2015
Q3 | – | Sell |
-8,079
| Closed | -$946K | – | 353 |
|
|
2015
Q2 | $946K | Buy |
+8,079
| New | +$883K | 0.08% | 150 |
|
|
2015
Q1 | – | Sell |
-8,634
| Closed | -$814K | – | 328 |
|
|
2014
Q4 | $814K | Buy |
8,634
+2,474
| +40% | +$256K | 0.1% | 140 |
|
|
2014
Q3 | $656K | Buy |
+6,160
| New | +$603K | 0.07% | 160 |
|
|
2014
Q2 | – | Sell |
-8,877
| Closed | -$629K | – | 365 |
|
|
2014
Q1 | $629K | Buy |
8,877
+4,515
| +104% | +$354K | 0.09% | 177 |
|
|
2013
Q4 | $328K | Sell |
4,362
-438
| -9% | -$30.5K | 0.03% | 208 |
|
|
2013
Q3 | $302K | Buy |
+4,800
| New | +$287K | 0.03% | 210 |
|
Other funds holding GILD
Virtu Financial's GILD Position: Q3 2024 in Review
Virtu Financial sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 14,838 shares — an estimated $1.02M sold.
Virtu Financial first reported a position in GILD in Q3 2013 and held it in 24 quarters. The position peaked at $4.63M in Q1 2024. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.
- Virtu Financial reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
- Virtu Financial sold 14,838 Gilead Sciences shares in Q3 2024, an estimated $1.02M.
- Virtu Financial first reported a position in Gilead Sciences in Q3 2013 and held it in 24 quarters.
- Virtu Financial's Gilead Sciences position peaked at $4.63M in Q1 2024.
- 1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.
Based on Virtu Financial's 13F filing for Q3 2024, filed 20 Nov 2024.